HYBRIGENICS: ENGAGEMENT IN DISCUSSIONS WITH CREDITORS TO CLEAN UP THE GROUP’S FINANCIAL SITUATION – 06/07/2024 at 6:30 p.m.


Illkirch, June 7, 2024 – 6:30 p.m. – The

Aton Group (Hybrigenics SA – Euronext Growth Paris – FR0004153930 – ALHYG)

announces that it has initiated discussions with its main creditors with a view to cleaning up the group’s financial situation.

As of December 31, 2023, the group had financial debt of €3.2 million, mainly made up of convertible bonds and a debt of €2.0 million from related parties (DMS Group). As of today, Aton has a cash horizon until July 2024.

As a reminder, on February 24, 2024, the group signed a memorandum of understanding with Vatel Capital aimed at staggering the repayment of the convertible bond loan of €1.5 million. This agreement made it possible to stagger the repayment of the bond maturing in October 2026 for part of the OCs

1

and maturing in October 2027 for all CBs

2

.

Taking into account the financial situation of the group, a holding company with no operational activity which will no longer have any employees at the end of June 2024, and the ongoing restructuring of the subsidiaries, the clearance of liabilities would make it possible to extend the financial visibility of the band.

As part of ongoing constructive discussions, in particular with Vatel Capital and DMS Group,

the group should very soon be able to request the opening of a conciliation procedure allowing the settlement of its debts and the clearance of its liabilities.

In this context, the next general meeting cannot take place at the end of June 2024. The Company has submitted a request to the Mixed Commercial Court of Strasbourg in order to obtain a postponement until September 30, 2024 for the holding of its general meeting. The new date for this event will be communicated as soon as possible.


About ATON

ATON is a medical sciences industry group committed to the future of medicine, with the goal of improving patient care and the safety and effectiveness of treatments. ATON guides and develops a portfolio of cutting-edge companies, each with its specialty, working in synergy to advance the treatments of tomorrow.

More information on www.aton-group.com.

ATON (formerly Hybrigenics)

is listed on the Euronext Growth market of Euronext Paris

ISIN: FR0004153930 – Memo: ALHYG – PEA-SME eligible


ATON (formerly Hybrigenics)


Leone ATAYI

Executive Director

[email protected]


This publication has the “🔒 Actusnews SECURITY MASTER” service.


– SECURITY MASTER Key:

lJ1rZspl5mYy5tyZZVraJZml5mWm2GXl5eVlGdol52YmJponWxpbJWbZnFnlmxt

– To control this key:

https://www.security-master-key.com.



Regulated information:


Inside information:

– Other press releases


Full and original press release in PDF format:

https://www.actusnews.com/news/86177-aton-cp-discussions-creanciers-07062024-vdef.pdf

© Copyright Actusnews Wire

Receive future company press releases free of charge by email by subscribing to www.actusnews.com



Source link -86